Lianru Zhang

1.9k total citations
35 papers, 1.1k citations indexed

About

Lianru Zhang is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Lianru Zhang has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Oncology. Recurrent topics in Lianru Zhang's work include Heat shock proteins research (10 papers), Immunotherapy and Immune Responses (7 papers) and ATP Synthase and ATPases Research (5 papers). Lianru Zhang is often cited by papers focused on Heat shock proteins research (10 papers), Immunotherapy and Immune Responses (7 papers) and ATP Synthase and ATPases Research (5 papers). Lianru Zhang collaborates with scholars based in China. Lianru Zhang's co-authors include Baorui Liu, Huizi Sha, Shu Su, Fanyan Meng, Fangjun Chen, Jie Shao, Lixia Yu, Hanqing Qian, Zhengyun Zou and Rutian Li and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Lianru Zhang

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lianru Zhang China	17	634	295	267	249	164	35	1.1k
Anabel Sorolla Spain	22	791 1.2×	262 0.9×	114 0.4×	144 0.6×	140 0.9×	49	1.3k
William Avery United States	8	1.1k 1.7×	291 1.0×	203 0.8×	146 0.6×	202 1.2×	16	1.7k
Funan Liu China	20	613 1.0×	302 1.0×	140 0.5×	265 1.1×	170 1.0×	54	1.3k
Maura Montani Italy	24	712 1.1×	340 1.2×	183 0.7×	112 0.4×	117 0.7×	43	1.3k
Heesun Cheong South Korea	24	1.3k 2.1×	180 0.6×	151 0.6×	167 0.7×	86 0.5×	51	2.3k
Guifeng Zhang China	12	915 1.4×	248 0.8×	166 0.6×	178 0.7×	41 0.3×	41	1.3k
Ji‐Feng Shi China	18	720 1.1×	190 0.6×	88 0.3×	286 1.1×	436 2.7×	40	1.2k
Giulia Russo Italy	29	1.3k 2.0×	326 1.1×	121 0.5×	104 0.4×	139 0.8×	61	1.8k
Padma Shastry India	21	698 1.1×	218 0.7×	312 1.2×	73 0.3×	48 0.3×	48	1.3k
Jinxu Fang United States	9	282 0.4×	201 0.7×	125 0.5×	134 0.5×	162 1.0×	10	611

Countries citing papers authored by Lianru Zhang

Since Specialization

Citations

This map shows the geographic impact of Lianru Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianru Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianru Zhang more than expected).

Fields of papers citing papers by Lianru Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianru Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianru Zhang. The network helps show where Lianru Zhang may publish in the future.

Co-authorship network of co-authors of Lianru Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Lianru Zhang. A scholar is included among the top collaborators of Lianru Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianru Zhang. Lianru Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Jie, et al.. (2023). Expression of four cancer-testis antigens in TNBC indicating potential universal immunotherapeutic targets. Journal of Cancer Research and Clinical Oncology. 149(16). 15003–15011. 7 indexed citations

Chu, Yanhong, Yaohua Ke, Xiaoyu Feng, et al.. (2022). Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma. Journal of Nanobiotechnology. 20(1). 190–190. 40 indexed citations

Zhang, Lianru, et al.. (2022). Recent Progress on Therapeutic Vaccines for Breast Cancer. Frontiers in Oncology. 12. 905832–905832. 12 indexed citations

Wang, Liman, et al.. (2019). <p>Novel Hsp90 Inhibitor C086 Potently Inhibits Non-Small Cell Lung Cancer Cells As A Single Agent Or In Combination With Gefitinib</p>. Cancer Management and Research. Volume 11. 8937–8945. 11 indexed citations

Ding, Naiqing, Zhengyun Zou, Huizi Sha, et al.. (2019). iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer. Nature Communications. 10(1). 1336–1336. 94 indexed citations

Chen, Hong, Huizi Sha, Lianru Zhang, et al.. (2018). Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein. International Journal of Nanomedicine. Volume 13. 5347–5359. 76 indexed citations

Zhang, Lianru, et al.. (2017). C1206, a novel curcumin derivative, potently inhibits Hsp90 and human chronic myeloid leukemia cells in vitro. Acta Pharmacologica Sinica. 39(4). 649–658. 24 indexed citations

Huang, Ying, Xihan Li, Huizi Sha, et al.. (2017). sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatment. Scientific Reports. 7(1). 579–579. 21 indexed citations

Zhang, Lianru, Rutian Li, Hong Chen, et al.. (2017). Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer. International Journal of Nanomedicine. Volume 12. 2129–2142. 117 indexed citations

10.

Zhang, Liyuan, Zhenlong Yu, Yan Wang, et al.. (2016). Quantitative proteomics reveals molecular mechanism of gamabufotalin and its potential inhibition on Hsp90 in lung cancer. Oncotarget. 7(47). 76551–76564. 26 indexed citations

11.

Huang, Wei, et al.. (2014). FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation. Molecular Cancer. 13(1). 150–150. 65 indexed citations

12.

Peng, Lin, Yuting Yi, Miaomiao Wang, et al.. (2014). Heat shock protein 90 inhibitor mycoepoxydiene modulates kinase signaling in cervical cancer cells and inhibits in-vivo tumor growth. Anti-Cancer Drugs. 26(1). 25–34. 9 indexed citations

13.

Geng, Jing, S. Y. Xiao, Zhonghui Zheng, Siyang Song, & Lianru Zhang. (2012). Gambogic acid protects from endotoxin shock by suppressing pro-inflammatory factors in vivo and in vitro. Inflammation Research. 62(2). 165–172. 16 indexed citations

14.

Zhang, Lianru, Yuting Yi, Yifei Sun, et al.. (2011). Hsp90 interacts with AMPK and mediates acetyl-CoA carboxylase phosphorylation. Cellular Signalling. 24(4). 859–865. 29 indexed citations

15.

Liu, Jingjing, Lianru Zhang, Yan-yan Zhan, et al.. (2010). A Unique Pharmacophore for Activation of the Nuclear Orphan Receptor Nur77 In vivo and In vitro. Cancer Research. 70(9). 3628–3637. 89 indexed citations

16.

Zhang, Lianru. (2010). Study on a Screening Model for Inhibitor of Hsp90 ATPase Activity. Journal of Xiamen University. 6 indexed citations

17.

Zhang, Lianru. (2008). Study on Bioactivity of Endophytic Fungi from Ephedra. Journal of Xiamen University. 1 indexed citations

18.

Zhang, Lianru. (2007). Study on Antioxidant Activity of Marine Fungi. Journal of Xiamen University. 1 indexed citations

19.

Zhang, Lianru & Guolin Zou. (2004). Flavanol of Limonium bicolor. Chemistry of Natural Compounds. 40(6). 602–603. 4 indexed citations

20.

Zhang, Lianru, et al.. (2000). Review of development in ephedta^s chemical researching and using. Europe PMC (PubMed Central). 19(3). 87–90. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact